Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.
#biontech #clinicaltrial #newsrelease #pfizer #vaccinecandidate